首页> 美国卫生研究院文献>other >Self-Reported Discrimination Diabetes Distress and Continuous Blood Glucose in Women with Type 2 Diabetes
【2h】

Self-Reported Discrimination Diabetes Distress and Continuous Blood Glucose in Women with Type 2 Diabetes

机译:自我报告的歧视糖尿病困扰和2型糖尿病女性的持续血糖

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

We investigated whether self-reported racial discrimination was associated with continuous glucose levels and variability in individuals with diabetes, and whether diabetes distress mediated these associations. Seventy-four Black and White women with type 2 diabetes completed the Experience of Discrimination scale, a measure of lifetime racial discrimination, and the Problem Areas in Diabetes, a measure of diabetes distress. Participants wore a continuous glucose monitor for 24 h after 8 h of fasting, a standard meal, and a 4-h run in period. Higher discrimination predicted higher continuous mean glucose and higher standard deviation of glucose. For both mean and standard deviation of glucose, a race × discrimination interaction indicated a stronger relationship between discrimination and glucose for Whites than for Blacks. Diabetes distress mediated the discrimination–mean glucose relationship. Whites who report discrimination may be uniquely sensitive to distress. These preliminary findings suggest that racial discrimination adversely affects glucose control in women with diabetes, and does so indirectly through diabetes distress. Diabetes distress may be an important therapeutic target to reduce the ill effects of racial discrimination in persons with diabetes.
机译:我们调查了自我报告的种族歧视是否与糖尿病患者的持续血糖水平和变异性相关,以及糖尿病困扰是否介导了这些相关性。 74名患有2型糖尿病的黑人和白人妇女完成了“歧视经历”量表(一种终生种族歧视的量度)和“糖尿病问题领域”(一种衡量糖尿病困扰的量度)。参与者在禁食8小时,标准餐食和4小时磨合期后的24小时内都佩戴连续葡萄糖监测仪。较高的辨别力预测较高的连续平均葡萄糖和较高的葡萄糖标准偏差。对于葡萄糖的均值和标准差,种族×辨别力相互作用表明,白人的辨别力和葡萄糖之间的关系比黑人更强。糖尿病困扰介导了歧视-平均血糖的关系。报告歧视的白人可能对遇难特别敏感。这些初步发现表明,种族歧视会对糖尿病女性的血糖控制产生不利影响,并通过糖尿病困扰间接影响。糖尿病困扰可能是减少种族歧视对糖尿病患者的不良影响的重要治疗目标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号